These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13206681)

  • 21. Studies of prothrombin and proconvertin (SPCA); concentrations in plasma of patients with pernicious anemia in remission, treated with vitamin B12.
    VETNE G; AXELROD AR
    Am J Clin Pathol; 1954 Jul; 24(7):796-801. PubMed ID: 13171349
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of the marrow in prothrombin and proconvertin synthesis.
    GORDIN R
    Acta Haematol; 1958 Jun; 19(6):341-6. PubMed ID: 13570906
    [No Abstract]   [Full Text] [Related]  

  • 23. [Methodological and clinical studies on the isolated determination of coagulation factor VII and prothrombin].
    WITTE S; DIRNBERGER P
    Dtsch Arch Klin Med; 1952; 199(5-6):492-501. PubMed ID: 13033518
    [No Abstract]   [Full Text] [Related]  

  • 24. Congenital familial deficiency of the stable prothrombin conversion factor; restudy of case originally reported as idiopathic hypoprothrombinemia.
    FRICK PG; HAGEN PS
    J Lab Clin Med; 1953 Aug; 42(2):212-23. PubMed ID: 13069867
    [No Abstract]   [Full Text] [Related]  

  • 25. PROTHROMBIN LEVELS DURING THE FIRST YEAR OF LIFE. OBSERVATIONS FOLLOWED BY THE SYNTHETIC SUBSTRATE (TAME) ASSAY OF NORMAL FULL-TERM INFANTS.
    GLUECK HI; SUTHERLAND J; GLESER G
    Am J Dis Child; 1964 Jun; 107():612-7. PubMed ID: 14133821
    [No Abstract]   [Full Text] [Related]  

  • 26. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 28. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proconvertin and prothrombin content in children following Botkin's disease in the presence of residual changes and complications in the bile tracts].
    Zhuravlev NP
    Vopr Okhr Materin Det; 1968 Jul; 13(7):87. PubMed ID: 5720201
    [No Abstract]   [Full Text] [Related]  

  • 30. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the prothrombin-proconvertin determinations (Owren-Aas) with prothrombin-index obtained with the Larsen-Plum prothrombin time method.
    LUND E; GEILL T; SØNDERGAARD E; DAM H
    Scand J Clin Lab Invest; 1955; 7(1):69-74. PubMed ID: 14396286
    [No Abstract]   [Full Text] [Related]  

  • 32. [The mechanism of formation of coagulating factors prothrombin and factor VII].
    LASCH HG; ROKA L
    Klin Wochenschr; 1954 May; 32(19-20):460-4. PubMed ID: 13164277
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of synthetic vitamin K1 on prothrombin, factor VII complex and factor IX in premature infants].
    YOSHIDA K; MORII N; KANMI M; YOSHIDA K
    Paediatr Jpn; 1963 Jun; 67():373-8. PubMed ID: 14002672
    [No Abstract]   [Full Text] [Related]  

  • 34. SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES.
    HELLEMANS J; VORLAT M; VERSTRAETE M
    Br J Haematol; 1963 Oct; 9():506-12. PubMed ID: 14076133
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity.
    RODMAN T; PASTOR BH; FAWCETT KC
    Am J Med; 1961 Oct; 31():547-54. PubMed ID: 14493137
    [No Abstract]   [Full Text] [Related]  

  • 36. [Behavior of prothrombin and of factor VII in various pediatric diseases].
    DIGIGLIO G; FELICI W; STEGAGNO GA
    Arch Ital Pediatr Pueric; 1956; 18(1):37-64. PubMed ID: 13373544
    [No Abstract]   [Full Text] [Related]  

  • 37. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of coagulation time obtained with the one-stage method according to Quick (prothrombin time) and according to Owren (prothrombin-proconvertin time) in the control of coumarin treatment].
    CLETON FJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1835-6. PubMed ID: 13810671
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison between micro-modifications of prothrombin-proconvertin determinations and of the prothrombin time method.
    DYGGVE H
    Scand J Clin Lab Invest; 1958; 10(1):1-4. PubMed ID: 13555683
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in the clotting factors prothrombin & factor VII in hyper- & hypo-circulatory circulation shifts in cats].
    LASCH HG; MECHELKE K; NUSSER E
    Dtsch Arch Klin Med; 1957; 204(1):1-21. PubMed ID: 13447622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.